Two out of three patients with schizophrenia will fail to adhere to their medication as prescribed. The new tool includes eight factors that can be related to nonadherence.
A new screening tool has been developed and used in a survey of patients with schizophrenia that can help practitioners identify medication noncompliance. According to results of the National Adherence Initiative for Schizophrenia survey, which were released this week at the 160th Annual Meeting of the American Psychiatric Association (APA), two out of three patients with schizophrenia will fail to adhere to their medication as prescribed. The new tool includes eight factors that can be related to nonadherence, including the three most common: poor insight into illness (74%), previous discontinuation of medication on own (68%), and forgetting to take medication (67%). According to the study's lead investigator, identification of noncompliant patients can help clinicians intervene when appropriate.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.